Actively Recruiting

Age: 6Years +
All Genders
Healthy Volunteers
ID02357238

Genetics of Uveitis

Led by The Cleveland Clinic · Updated on 2026-03-04

1500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying uveitis, an eye condition, to better understand its causes and the underlying disease mechanisms. This observational study is focused on collecting genetic information from patients with uveitis, including those with infectious forms like toxoplasmosis retinochoroiditis and herpes-associated retinitis. The goal is to analyze DNA to identify genetic mutations or associations linked to the condition. Participants with uveitis will provide blood samples, from which DNA will be isolated and sequenced. The study does not involve treatment or medication but focuses on gathering genetic data from both infectious and non-infectious uveitis patients. The study duration includes a follow-up period of 5 years to observe outcomes related to non-infectious and infectious uveitis. During the study, participants will be involved in blood sample collection for genetic analysis. Researchers will monitor the progression of uveitis over five years to assess genetic links and disease patterns. The study includes participants aged 6 years and older, and healthy volunteers may also participate. Data collected will help improve understanding of uveitis and its genetic factors.

CONDITIONS

Brief Title

Genetics of Uveitis

Who Can Participate

Age: 6Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Any patient diagnosed with uveitis
  • Any patient diagnosed with infectious uveitis such as toxoplasmosis retinochoroiditis or herpes-associated retinitis
  • Age 6 years or older
Not Eligible

You will not qualify if you...

  • Patients unable to give consent
  • Patients from whom an adequate blood sample cannot be obtained
  • Patients younger than 6 years old (implied by minimum age requirement if relevant to exclude explicitly)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Long-term Monitoring

Duration - Up to 5 years

Participants with uveitis are observed over time to collect data related to their condition.

Trial Site Locations

Total: 1 location

1

Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

K

Kimberly M Baynes, BSN, RN, COA

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here